PubMed=10457905
Tohru Sugimoto, Yoshihiro Komada, Minoru Sakurai, Yoshihiro Horii, Ryuichi Morishita, Ryozo Nagai, Katsuhito Takahashi, Yujiro Asada;
Smooth muscle myosin of SM1 and SM2 isoforms expressing human neuroblastoma cell line of MP-N-MS.
Hum. Cell 12:47-56(1999)

PubMed=11129446; DOI=10.1097/00019606-200012000-00007
Tohru Sugimoto, Hiroshi Mine, Yoshihiro Horii, Katsuhito Takahashi, Ryozo Nagai, Ryuichi Morishita, Mihiro Komada, Yujiro Asada, Tadashi Sawada;
Neuroblastoma cell lines showing smooth muscle cell phenotypes.
Diagn. Mol. Pathol. 9:221-228(2000)

PubMed=12702577
Fumiko Saito-Ohara, Issei Imoto, Jun Inoue, Hajime Hosoi, Akira Nakagawara, Tohru Sugimoto, Johji Inazawa;
PPM1D is a potential target for 17q gain in neuroblastoma.
Cancer Res. 63:1876-1883(2003)

PubMed=23268333; DOI=10.1016/j.canlet.2012.12.011
Tohru Sugimoto, Takahiro Gotoh, Shigeki Yagyu, Hiroshi Kuroda, Tomoko Iehara, Hajime Hosoi, Sigeru Ohta, Miki Ohira, Akira Nakagawara;
A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell lines.
Cancer Lett. 331:115-121(2013)

CLPUB00582
Tohru Sugimoto, Hiroshi Kuroda, Shigeki Yagyu, Takahiro Gotoh, Shinya Osone, Shinichi Tamura, Tomoko Iehara, Hajime Hosoi;
Cellular and molecular characteristics of established neuroblastoma cell lines.
J. Cancer Res. Therap. Oncol. 7:201.1-201.15(2019)